Multiple Strategies for Recombinant Expression of Human Chymotrypsinogen C in Pichia Pastoris

Abstract

Chymotrypsin C (CTRC) is a multifunctional serine protease that have shown great application potential in the field of food processing. This study aims to efficiently express CTRC in Pichia pastoris and provide a safe and highly effective new enzyme formulation for the food industry. Here, we successfully expressed and secreted human chymotrypsinogen C (proCTRC) in P. pastoris through multiple strategies. First, we replaced the native AOX1 promoter with the stronger HpFMD promoter and used ribosomal DNA (rDNA) loci for gene integration to achieve significant expression and secretion of proCTRC. In addition, we designed a mutant pro2M that prevented host protease cleavage by replacing the dipeptide motif “KR” with “EK”. The enzyme activity of wild type and mutant pro2M in the fermentation supernatant reached 0.59 ± 0.003 U/mL and 3.94 ± 0.27 U/mL, respectively. Meanwhile, the mutant showed a specific activity of 54.84 U/mg, 3.3-fold higher than the wild type's 16.6 U/mg. Further, the recombinant pro2M and proCTRC can exhibite good stability under neutral pH conditions. In summary, we have established P. pastoris as a powerful platform for high-yield CTRC production and highlighted the importance of engineering protease-resistant variants to optimize enzyme secretion and activity.

Keywords

chymotrypsin C / Kex2 / Pichia pastoris / recombinant expression

References

[1] Ahmad, M., C. M. Winkler, M. Kolmbauer, H. Pichler, H. Schwab, and A. Emmerstorfer-Augustin. 2019. “Pichia Pastoris Protease-Deficient and Auxotrophic Strains Generated by a Novel, User-Friendly Vector Toolbox for Gene Deletion.” Yeast 36, no. 9: 557–570. https://doi.org/10.1002/yea.3426.

[2] Ahmed, U., T. Stadelmann, D. Heid, et al. 2024. “A Novel, Robust Peptidyl-Lys Metalloendopeptidase From Trametes Coccinea Recombinantly Expressed in Komagataella Phaffii.” Applied Microbiology and Biotechnology 108, no. 1: 103. https://doi.org/10.1007/s00253-023-12986-3.

[3] Aw, R., and K. M. Polizzi. 2016. “Liquid PTVA: A Faster and Cheaper Alternative for Generating Multi-Copy Clones in Pichia Pastoris.” Microbial Cell Factories 15, no. 1: 29. https://doi.org/10.1186/s12934-016-0432-8.

[4] Batra, J., A. Szabó, T. R. Caulfield, A. S. Soares, M. Sahin-Tóth, and E. S. Radisky. 2013. “Long-Range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme Activation.” Journal of Biological Chemistry 288, no. 14: 9848–9859. https://doi.org/10.1074/jbc.M113.457382.

[5] Bence, M., and M. Sahin-Tóth. 2011. “Asparagine-Linked Glycosylation of Human Chymotrypsin C Is Required for Folding and Secretion but Not for Enzyme Activity.” FEBS Journal 278, no. 22: 4338–4350. https://doi.org/10.1111/j.1742-4658.2011.08351.x.

[6] Brady, J. R., C. A. Whittaker, M. C. Tan, et al. 2020. “Comparative Genome-Scale Analysis of Pichia Pastoris Variants Informs Selection of an Optimal Base Strain.” Biotechnology and Bioengineering 117, no. 2: 543–555. https://doi.org/10.1002/bit.27209.

[7] Cereghino, J. L., and J. M. Cregg. 2000. “Heterologous Protein Expression in the Methylotrophic Yeast Pichia Pastoris.” FEMS Microbiology Reviews 24, no. 1: 45–66. https://doi.org/10.1111/j.1574-6976.2000.tb00558.x.

[8] Curvers, S., P. Brixius, T. Klauser, et al. 2001. “Human Chymotrypsinogen B Production With Pichia Pastoris by Integrated Development of Fermentation and Downstream Processing. Part 1. Fermentation.” Biotechnology Progress 17: 495–502. https://doi.org/10.1021/bp000188m.

[9] Folk, J. E., and E. W. Schirmer. 1965. “Chymotrypsin C. I. Isolation of the Zymogen and the Active Enzyme: Preliminary Structure and Specificity Studies.” Journal of Biological Chemistry 240, no. 1: 181–192. https://www.researchgate.net/publication/9331621_Chymotrypsin_C_I_Isolation_of_the_zymogen_and_the_active_enzyme_Preliminary_structure_and_specificity_studies.

[10] Gao, J., J. Xu, Y. Zuo, et al. 2022. “Synthetic Biology Toolkit for Marker-Less Integration of Multigene Pathways into Pichia Pastoris via CRISPR/Cas9.” ACS Synthetic Biology 11, no. 2: 623–633. https://doi.org/10.1021/acssynbio.1c00307.

[11] Hartner, F. S., C. Ruth, and D. Langenegger, et al. 2008. “Promoter Library Designed for Fine-Tuned Gene Expression in Pichia Pastoris.” Nucleic Acids Research 36, no. 12: e76. https://doi.org/10.1093/nar/gkn369.

[12] Marx, H., A. Mecklenbräuker, B. Gasser, M. Sauer, and D. Mattanovich. 2009. “Directed Gene Copy Number Amplification Inpichia Pastorisby Vector Integration Into the Ribosomal DNA Locus.” FEMS Yeast Research 9, no. 8: 1260–1270. https://doi.org/10.1111/j.1567-1364.2009.00561.x.

[13] Masson, E., J.-M. Chen, V. Scotet, C. Le Maréchal, and C. Férec. 2008. “Association of Rare Chymotrypsinogen C (CTRC) Gene Variations in Patients With Idiopathic Chronic Pancreatitis.” Human Genetics 123, no. 1: 83–91. https://doi.org/10.1007/s00439-007-0459-3.

[14] Matsuoka, T., T. Kawashima, T. Nakamura, and T. Yabe. 2017. “Characterization and Comparison of Recombinant Honeybee Chymotrypsin-Like Protease (HCLPase) Expressed in Escherichia coli and Insect Cells.” Bioscience, Biotechnology, and Biochemistry 81, no. 7: 1401–1404. https://doi.org/10.1080/09168451.2017.1318698.

[15] Rosendahl, J., H. Witt, R. Szmola, et al. 2008. “Chymotrypsin C (CTRC) Variants That Diminish Activity or Secretion Are Associated With Chronic Pancreatitis.” Nature Genetics 40: 78–82. https://doi.org/10.1038/ng.2007.44.

[16] Shen, W., M. Shu, L. Ma, H. Ni, and H. Yan. 2016. “High Level Expression of Organophosphorus Hydrolase in Pichia Pastoris by Multicopy ophcM Assembly.” Protein Expression and Purification 119: 110–116. https://doi.org/10.1016/j.pep.2015.11.012.

[17] Sun, X., H. Liu, P. Wang, et al. 2019. “Construction of a Novel MK-4 Biosynthetic Pathway in Pichia Pastoris Through Heterologous Expression of HsUBIAD1.” Microbial Cell Factories 18, no. 1: 169. https://doi.org/10.1186/s12934-019-1215-9.

[18] Sunga, A. J., I. Tolstorukov, and J. M. Cregg. 2008. “Posttransformational Vector Amplification in the Yeastpichia Pastoris.” FEMS Yeast Research 8, no. 6: 870–876. https://doi.org/10.1111/j.1567-1364.2008.00410.x.

[19] Szmola, R., and M. Sahin-Tóth. 2007. “Chymotrypsin C (Caldecrin) Promotes Degradation of Human Cationic Trypsin: Identity With Rinderknecht's Enzyme Y.” Proceedings of the National Academy of Sciences of the United States of America 104, no. 27: 11227–11232. https://doi.org/10.1073/pnas.0703714104.

[20] Tomomura, A., K. Bandow, and M. Tomomura. 2021. “Purification and Biological Function of Caldecrin.” Medicines 8, no. 8: 41. https://doi.org/10.3390/medicines8080041.

[21] Tomomura, M. 2015. “Caldecrin: A Pancreas-Derived Hypocalcemic Factor, Regulates Osteoclast Formation and Function.” World Journal of Biological Chemistry 6, no. 4: 358. https://doi.org/10.4331/wjbc.v6.i4.358.

[22] Vogl, T., J. E. Fischer, P. Hyden, R. Wasmayer, L. Sturmberger, and A. Glieder. 2020. “Orthologous Promoters From Related Methylotrophic Yeasts Surpass Expression of Endogenous Promoters of Pichia Pastoris.” AMB Express 10, no. 1: 38. https://doi.org/10.1186/s13568-020-00972-1.

[23] Vogl, T., L. Sturmberger, T. Kickenweiz, et al. 2016. “A Toolbox of Diverse Promoters Related to Methanol Utilization: Functionally Verified Parts for Heterologous Pathway Expression in Pichia Pastoris.” ACS Synthetic Biology 5, no. 2: 172–186. https://doi.org/10.1021/acssynbio.5b00199.

[24] Wang, F., J. Sun, W. Guo, and Y. Wu. 2024. “Application of the Insect Cell-Baculovirus Expression Vector System in Adeno-Associated Viral Production.” Applied Sciences 14, no. 23: 10948. https://doi.org/10.3390/app142310948.

[25] Wang, F., X. Wang, X. Yu, et al. 2015. “High-Level Expression of Endo-β-N-Acetylglucosaminidase H From Streptomyces Plicatus in Pichia Pastoris and Its Application for the Deglycosylation of Glycoproteins.” PLoS One 10, no. 3: e0120458. https://doi.org/10.1371/journal.pone.0120458.

[26] Wang, H. Y. D., R. Xu, and C.-W. Chi. 2011. “Purification, cDNA Cloning, and Recombinant Expression of Chymotrypsin C From Porcine Pancreas.” Acta Biochimica et Biophysica 43, no. 7: 568–575. https://doi.org/10.1093/abbs/gmr047.

[27] Wu, S., and G. J. Letchworth. 2004. “High Efficiency Transformation by Electroporation of Pichia Pastoris Pretreated With Lithium Acetate.” Biotechniques 36, no. 1: 152–154. https://doi.org/10.2144/04361DD02.

[28] Yamada, R., K. Ogura, Y. Kimoto, and H. Ogino. 2019. “Toward the Construction of a Technology Platform for Chemicals Production From Methanol: D-Lactic Acid Production From Methanol by an Engineered Yeast Pichia Pastoris.” World Journal of Microbiology and Biotechnology 35, no. 2: 37. https://doi.org/10.1007/s11274-019-2610-4.

[29] Yang, H., C. Zhai, X. Yu, et al. 2016. “High-Level Expression of Proteinase K From Tritirachium Album Limber in Pichia Pastoris Using Multi-Copy Expression Strains.” Protein Expression and Purification 122: 38–44. https://doi.org/10.1016/j.pep.2016.02.006.

[30] Zhang, Y., H. Huang, X. Yao, G. Du, J. Chen, and Z. Kang. 2018. “High-Yield Secretory Production of Stable, Active Trypsin Through Engineering of the N-Terminal Peptide and Self-Degradation Sites in Pichia Pastoris.” Bioresource Technology 247: 81–87. https://doi.org/10.1016/j.biortech.2017.08.006.

[31] Zhou, J., and M. Sahin-Tóth. 2011. “Chymotrypsin C Mutations in Chronic Pancreatitis.” Journal of Gastroenterology and Hepatology 26, no. 8: 1238–1246. https://doi.org/10.1111/j.1440-1746.2011.06791.x.

RIGHTS & PERMISSIONS

2025 The Author(s). Food Bioengineering published by John Wiley & Sons Australia, Ltd on behalf of State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology.